Glucosamine/Chondroitin Supplier Selection Delays NIH Study
This article was originally published in The Tan Sheet
Executive Summary
Difficulty in choosing a U.S. company to supply glucosamine and chondroitin sulfate has delayed the start of the NIH-funded study on osteoarthritis.